Inventor · disambiguated record
Yan Yang
Also filed as: YANG YAN · Yang yan ling
10 granted patents·25 pending applications·9 citations·filing 2004–2025
80Inventor score
Files withFOREST LABORATORIES5JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD4FOREST LAB HOLDINGS LTD3UNIV ZHEJIANG3Yang yan ling3
Top patents by PatentIndex Score
35 records- 0183US11471428B2Method and pharmaceutical composition for treating depressionUNIV ZHEJIANG·Filed 2019·Granted Oct 18, 2022·4 cites·11 claims
- 0275US11643405B2Compound for treatment or prevention of liver diseasesJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2019·Granted May 9, 2023·1 cites·8 claims
- 0371US10336710B2Benzimidazole derivatives, preparation method therefor, and applications thereofBEIJING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jul 2, 2019·4 cites·12 claims
- 0464US2024002308A1Soil-structure improving bio-organic fertilizer and preparation method thereofBINZHOU JINGYANG BIOLOGICAL FERTILIZER CO LTD·Filed 2023·Application pending·0 cites
- 0564US2010035995A1Compositions comprising Cyclohexylamines and AminoadamantanesMERZ PHARMA GMBH & CO KGAA·Filed 2009·Application pending·0 cites
- 0663US12426614B2Lentinula edodes-derived saltiness enhancing peptide, method for preparing the same and use thereofSHANGHAI ACAD AGRI SCIENCES·Filed 2024·Granted Sep 30, 2025·0 cites·10 claims
- 0763US2010028427A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LABORATORIES·Filed 2009·Application pending·0 cites
- 0861US11326168B2Use of potassium channel inhibitor for treating depressionUNIV ZHEJIANG·Filed 2019·Granted May 10, 2022·0 cites·7 claims
- 0961US2023050684A1Use of potassium channel inhibitor for treating depressionUNIV ZHEJIANG·Filed 2022·Application pending·0 cites
- 1059US2014348932A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 1159US2025281975A1High-purity tantalum powder and preparation method thereforNINGXIA ORIENT TANTALUM IND CO LTD·Filed 2022·Application pending·0 cites
- 1258US2014350114A1Compositions comprising cyclohexylamines and aminoadamantanesMERZ PHARMA GMBH & CO KGAA·Filed 2014·Application pending·0 cites
- 1358US2025282753A1Compounds useful for reducing uric acidATOM BIOSCIENCE AMERICA CORP·Filed 2023·Application pending·0 cites
- 1458US2025289809A1Compounds useful for goutATOM BIOSCIENCE AMERICA CORP·Filed 2023·Application pending·0 cites
- 1554US2025129012A1Anti-inflammatory and analgesic compounds and use thereofJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1654US2024262808A1Xanthine oxidase inhibitorJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1754US2007270500A1Compositions Comprising Cyclohexylamines and AminoadamantanesDEDHIYA MAHENDRA G·Filed 2004·Application pending·0 cites
- 1854US2006198884A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 1953US8834924B2Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneYANG YAN·Filed 2011·Granted Sep 16, 2014·0 cites·19 claims
- 2053US2006002999A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 2153US2025368639A1Solid forms of a compound for treating or preventing hyperuricemia or goutATOM THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 2252US2012238631A1Compositions comprising cyclohexylamines and aminoadamantanesDEDHIYA MAHENDRA G·Filed 2012·Application pending·0 cites
- 2349US2006165789A1Lercanidipine modified release compositionsFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 2447US11597725B2URAT1 inhibitor for promoting uric acid excretionJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2018·Granted Mar 7, 2023·0 cites·10 claims
- 2547US2023416329A1A peptide with disulfide bonds and inhibitory activity against serine proteases, derived hybrid peptides thereof, and uses thereofINST OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCICENCES·Filed 2021·Application pending·0 cites
- 2646US2014023710A1Milnacipran formulationsFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 2744US2007134322A1Modified and pulsatile release pharmaceutical formulations of escitalopramFOREST LABORATORIES·Filed 2006·Application pending·0 cites
- 2843US2025188180A1Anti-cd40 nanobody, and preparation method therefor and use thereofBIOINTRON BIOLOGICAL INC·Filed 2025·Application pending·0 cites
- 2940US11203577B2Sulfonyl-structure-containing triazinone derivatives, their preparation methods and their uses in insect killing and/or bacterium killingUNIV NANKAI·Filed 2017·Granted Dec 21, 2021·0 cites·9 claims
- 3039US2010286260A1Milnacipran formulationsFOREST LAB HOLDINGS LTD·Filed 2010·Application pending·0 cites
- 3138US2015079158A1Method to stabilize liposome emulsions for biocidal deliverySHI YONGTAO·Filed 2012·Application pending·0 cites
- 3234US11608334B2Pyrrolo-aromatic heterocyclic compound, preparation method therefor, and medical use thereofTHE NAT INSTITUTES OF PHARMACEUTICAL R&D CO LTD·Filed 2017·Granted Mar 21, 2023·0 cites·14 claims
- 3330US2012041035A1Levamlodipine compound pharmaceutical compositionYang yan ling·Filed 2010·Application pending·0 cites
- 3429US8470363B2Antihypertensive pharmaceutical compositionYang yan ling·Filed 2010·Granted Jun 25, 2013·0 cites·19 claims
- 3528US2011313006A1PHARMACEUTICAL COMPOSITION OF LEVAMLODIPINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND β RECEPTOR BLOCKING AGENT, AND USE THEREOFYang yan ling·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yan Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →